WCM
BIO icon

Weld Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Weld Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,124
Closed -$655K – 331
2020
Q4 		$655K Buy
+1,124
New +$640K 0.26% 130
2020
Q3 		– Sell
-1,064
Closed -$480K – 493
2020
Q2 		$480K Sell
1,064
-2,655
-71% -$1.17M 0.19% 194
2020
Q1 		$1.3M Sell
3,719
-2,148
-37% -$790K 0.66% 24
2019
Q4 		$2.17M Buy
+5,867
New +$2.07M 0.42% 48

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Weld Capital Management's BIO Position: Q1 2021 in Review

Weld Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 1,124 shares — an estimated $655K sold.

Weld Capital Management first reported a position in BIO in Q4 2019 and held it in 4 quarters. The position peaked at $2.17M in Q4 2019. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • Weld Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • Weld Capital Management sold 1,124 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $655K.
  • Weld Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 4 quarters.
  • Weld Capital Management's Bio-Rad Laboratories Class A position peaked at $2.17M in Q4 2019.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.